Sales decline 65.81% to Rs 0.40 crore
Net profit of Earum Pharmaceuticals declined 97.08% to Rs 0.04 crore in the quarter ended December 2023 as against Rs 1.37 crore during the previous quarter ended December 2022. Sales declined 65.81% to Rs 0.40 crore in the quarter ended December 2023 as against Rs 1.17 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales0.401.17 -66 OPM %15.0011.97 -PBDT0.061.40 -96 PBT0.041.37 -97 NP0.041.37 -97Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
